How COVID-19 Impacting Computer-Aided Drug Discovery Market Globally?

Post COVID-19 Impact on Computer-Aided Drug Discovery Market

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues.

Research Dive' group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following:

o Long-term and short-term impact of Covid-19 on the market

o Cascading impact of Covid-19 on Computer-Aided Drug Discovery Market, due to the impact on its extended ecosystem

o Understanding the market behaviour Pre- and Post-COVID-19 pandemic

o Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity

We'll help you fight this crisis through our business intelligence solutions.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/159

Pre COVID-19 Analysis on Computer-Aided Drug Discovery Market

According to a study conducted by Research Dive, the globalcomputer-aided drug discovery market forecast size is expected to reach$4,878.5billion by the end of 2026, registering 15.5% CAGR over the forecast period.

The research institutes segment held the largest market value in 2018 accounting for $602.3 billion and is expected to reach $1,873.4 billion by 2026 @ https://www.researchdive.com/purchase-enquiry/159

Porter's Five Forces Analysis for Computer-Aided Drug Discovery Market:

o Bargaining Power of Suppliers: The key players present in this market arelimited and are catering the demand ofcomputer-aided drug discovery due to which the supplier's power is High.

o Bargaining Power of Consumers:The number of consumers is very highand thus the bargaining power of consumers isLow.

o Threat of new entrants: Initial investment to setup a computer-aided drug discovery organization is very high and thus the threat of new entrants is Low.

o Threat of substitutes:There is no alternative for computer-aided drug discovery, and thus the threat of substitutes is Low.

o Competitive rivalry in the industry:This market includes a fewmarket participants. Many of the key players are following similar strategies for the improvement of technologies.
The competitive rivalry in the industry isHigh.

Computer-aided drug design utilizes computational methods to analyze, develop, and discover similarbiologically active molecules. The ligand-based computer-aided drug discovery (LB-CADD) method includes the understanding of ligands which are known to interrelate with a targeted disease. These procedures use a set of referral structures that are collected from compounds known to interact with the target of interest and analyze their 2D or 3D structures.

The rising usage of pharmacodynamics and pharmacokinetic modelling in pre-clinical advancements is anticipated to drive the computer-aided drug discovery market's growth in the recent years. In addition, the rapid growth in the demand for latest technologies to decrease the cost associated with drug discovery and development is the major factor for the growth of computer-aided drug discovery market.

Inspiteofvarious positive factors, improper standardization in the drug discovery methodology has been a major point of concern. Along with the aforementioned factor, insufficient knowledge about various biological systems and processes due to which the drug development fails are the major factor that may hamper the market growth.
The global computer-aided drug discovery market is analyzed on the basis of type into Structure based drug design (SBDD), Ligand-Based Drug Design (LBDD) and Sequence-Based Approaches. Among these, the structure-based drug design market segmentis expected to drive the computer-aided drug discovery market growth which is anticipated to reach $1,585.5billion by 2026, growing at CAGR of 15.8% during the forecast period. However, LBDD segment had the highest market share in the year 2018 accounting for $606.9 billion and is expected to reach $1,878.2 billion by 2026 growing ata CAGR of 15.2% during the projected timeframe. This dominance is mainly attributed to the usage of LBDDthat is the first step in developing any drug and understanding a disease molecular structure, and developing a drug suitable to resist the disease is a time taking process.

The Ligand-based drug design segment held the largest market share in 2018, with a size of $606.9billion, and will further reach $1,878.2billion by 2026, at a CAGR of 15.2% @ https://www.researchdive.com/download-sample/159

Computer-Aided Drug Discovery Market Segmentation by Therapeutic Area

o Oncology
o Neurology
o Cardiovascular Disease
o Respiratory Disease
o Diabetes
o Others

On the basis of thetherapeutic area, the globalcomputer-aided drug discoverymarket is categorized into oncology, neurology, cardiovascular disease, respiratory disease and diabetes and others. Among these, the market for oncologysegment held the largest market share in 2018 accounting for $355.8billion. Cardiovascular diseases segment is anticipated to dominate the computer-aided drug discovery market during the forecasted period. This is because thenumber of patients suffering from cardiovascular diseases globally is increasing.Thus, to fight the various cardio vascular diseases, the key players are investing huge in developing better and enhanced drugs.

Computer-Aided Drug Discovery Market Segmentation by End-use

o Pharmaceutical Companies
o Biotechnology Companies
o Research Laboratories

Get Access to Full Report (TOC, Figures, Chart, etc.) @ https://www.researchdive.com/159/computer-aided-drug-discovery-market

Key Players

o Schrodinger (NASDAQ: SDGR)
o Charles River (NYSE: CRL)
o AstraZeneca (LON: AZN)
o Evotec A.G. (ETR: EVT)
o Bayers AG (ETR: BAYN)
o BOC Sciences
o Aris Pharmaceuticals
o Aragen Bioscience
o Albany Molecular Research Inc. (AMRI)
o BioDuro

The global computer-aided drug discoverymarket has been classified regionally into North America, Europe, Asia-Pacific, and LAMEA. The North America regionheld the largest market value in 2018 accounting for $432.9billion and is anticipated to reach $1,283.1billion by 2026, growing at a CAGR of 14.5% during the forecast period. Asia-Pacific region is expected to dominate the computer-aided drug discovery market; this growth is majorly due to the growing R&D expenditure by the organizations that are present in this region.

The number of people suffering from various diseases in this region is also growing due to the lack of money to buy costly medicines. Asia-Pacific region accounted for $411.3 billion in 2018 and is expected to reach $1,361.1 billion by 2026, growing at a CAGR of 16.1% during the forecast period.

Contact us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1-888-961-4454
E-mail: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521
Blog: https://www.researchdive.com/blog
Follow us: https://marketinsightinformation.blogspot.com/

About Us:
Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

This release was published on openPR.